Dynaval: A Non-Existent Medication in Clinical Guidelines
Based on a comprehensive review of the provided clinical guidelines and research evidence, "Dynaval" is not an existing medication recognized in any of the authoritative medical sources provided.
What the Evidence Shows
None of the provided clinical guidelines from the American College of Cardiology, American Heart Association, Heart Rhythm Society, or other authoritative sources mention a medication called "Dynaval" 1.
The comprehensive medication tables in the 2015 ACC/AHA/HRS guidelines for management of supraventricular tachycardia do not list Dynaval among antiarrhythmic medications, beta-blockers, calcium channel blockers, or other cardiac medications 1.
The detailed drug tables listing medications for cardiac conditions include specific agents such as dofetilide, sotalol, flecainide, propafenone, diltiazem, verapamil, and digoxin, but there is no mention of Dynaval 1.
Possible Confusion with Similar Medications
The name might be confused with diltiazem, a nondihydropyridine calcium channel antagonist used for hypertension and angina, typically dosed at 120-360 mg daily 2.
It could potentially be confused with dynasore, which is not a clinical medication but rather a research compound used as a cell-permeable inhibitor of dynamin in laboratory settings 3.
The name might also be confused with DynaMed, which is not a medication but an evidence-based clinical reference resource used by healthcare professionals 4, 5, 6.
Clinical Implications
Since Dynaval does not appear to be a recognized medication in current clinical guidelines, it should not be prescribed or administered to patients 1.
If a healthcare provider encounters this term in clinical practice, they should seek clarification about what medication is actually intended 2.
Medication errors can occur with sound-alike or look-alike drug names, so careful verification of any unfamiliar medication name is essential for patient safety 1.
Conclusion
If you are seeking information about a specific cardiac medication, consult with a healthcare provider for clarification about the correct medication name 1.
For cardiac conditions requiring medication management, established agents with proven efficacy and safety profiles as outlined in current clinical guidelines should be used 1.